These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Current clinical results of antiplatelet medication]. Ordinas A Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391 [No Abstract] [Full Text] [Related]
23. Effect of drugs of platelets and complications of vascular disease. Mustard JF; Packham MA; Kinlough-Rathbone RL Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448 [No Abstract] [Full Text] [Related]
24. Platelet aggregation secondary to coronary obstruction. Moore S Circulation; 1976 Mar; 53(3 Suppl):I66-9. PubMed ID: 767018 [TBL] [Abstract][Full Text] [Related]
25. A critical appraisal of the clinical efficiency of anti-platelet drugs. Lecompte T; Samama M Agents Actions Suppl; 1986; 20():203-14. PubMed ID: 3544741 [No Abstract] [Full Text] [Related]
26. [Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy]. Verstraete M Recenti Prog Med; 1980 Apr; 68(4):361-81. PubMed ID: 6992244 [No Abstract] [Full Text] [Related]
27. Platelet-active drugs in the secondary prevention of cardiovascular events: an overview. Weiss HJ Circulation; 1980 Dec; 62(6 Pt 2):V41-3. PubMed ID: 7002351 [TBL] [Abstract][Full Text] [Related]
29. API expert consensus document on management of ischemic heart disease. Association of Physicians of India J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697 [TBL] [Abstract][Full Text] [Related]
30. Are agents affecting platelet function clinically useful in patients with coronary artery disease? Verstraete M Acta Clin Belg; 1976; 31(4):229-32. PubMed ID: 1087523 [No Abstract] [Full Text] [Related]
31. Platelets and antiplatelet therapy in ischemic heart disease. Frishman WH; Miller KP Curr Probl Cardiol; 1986 Feb; 11(2):69-136. PubMed ID: 2936576 [No Abstract] [Full Text] [Related]
32. Platelet tests and antiplatelet drugs in coronary artery disease. de Boer AC; Han P; Turpie AG; Butt R; Gent M; Genton E Circulation; 1983 Mar; 67(3):500-4. PubMed ID: 6217921 [TBL] [Abstract][Full Text] [Related]
33. Role of platelets in the pathophysiology of acute coronary syndrome. Massberg S; Schulz C; Gawaz M Semin Vasc Med; 2003 May; 3(2):147-62. PubMed ID: 15199478 [TBL] [Abstract][Full Text] [Related]
34. [Inhibitors of thrombocytic function for prophylaxis of coronary heart disease (author's transl)]. Loew D; Breddin K; Uberla K MMW Munch Med Wochenschr; 1982 Jan; 124(1):46-56. PubMed ID: 6120454 [No Abstract] [Full Text] [Related]
35. [MDA formation by platelets and plasmatic BTG levels in patients suffering from acute myocardial infarction (author's transl)]. Davì G; Traina M; Novo S; Pinto A; Piraino GL; Marano G; Alfano R G Ital Cardiol; 1981; 11(9):1238-41. PubMed ID: 6173283 [TBL] [Abstract][Full Text] [Related]
36. [Place of antiplatelet agents in the prevention of cerebral ischemic strokes]. Bousser MG Ann Med Interne (Paris); 1983; 134(2):79-83. PubMed ID: 6349464 [No Abstract] [Full Text] [Related]
37. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review]. Verdecchia P G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978 [No Abstract] [Full Text] [Related]
39. Proceedings: A clinical trial of antiplatelet therapy in patients with coronary arterial disease. Michaels L; Galbraith PA; Ledwich JR Thromb Diath Haemorrh; 1975 Nov; 34(2):598-9. PubMed ID: 1105881 [No Abstract] [Full Text] [Related]
40. The current status of platelet suppressive drugs in the treatment of thrombosis. Hirsh J; Gent M; Genton E Thromb Diath Haemorrh; 1975 Jun; 33(3):406-16. PubMed ID: 1098213 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]